Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001140361-25-004894·Blue Owl Capital Holdings LP
Schedule 13G ownership disclosure
Sagimet Biosciences Inc
Series A common stock, $0.0001 par value per share · CUSIP: 786700104
Event date: 2024-12-31
- Filing-level shares
- 1,323,877
- Percent of class
- 4.32%
- Blue Owl Capital Holdings LP
Shares: 1,323,877 · Class: 4.32%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001140361-25-004894
- Form type
- SCHEDULE 13G/A
- Filer
- Blue Owl Capital Holdings LP
- CIK
- CIK 1858703
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership